Bank Of Montreal Amgen Inc Call Options Transaction History

Bank Of Montreal

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $1.28 Million - $1.44 Million	5,000 Added 100.0%	10,000 $2.88 Million
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $1.09 Million - $1.36 Million	5,000 New	5,000 $1.34 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $1.1 Million - $1.21 Million	5,000 New	5,000 $1.28 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.